MET-IN-1

MET-IN-1 (Compound 13) is a small molecule, orally bioavailable MET tyrosine kinase inhibitor. It demonstrates potent antitumor efficacy in preclinical models, showing activity in both cellular assays and in vivo studies for cancer research applications.